dr. gwin on the mechanism of action of 𝞪-tea in her2-positive metastatic breast cancer
Published 4 years ago • 37 plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
1:09
dr. gwin on the safety of α-tea plus trastuzumab in recurrent her2 breast cancer
-
1:31
dr. gwin on potential areas of investigation with alpha-tea and trastuzumab in breast cancer
-
2:05
dr. geyer discusses challenges in her2-positive metastatic breast cancer management
-
9:38
role of t-dm1 in her2-positive metastatic breast cancer
-
1:17
comment: phase 3 study shows her2 therapy clinically meaningful for metastatic breast cancer pts
-
1:47
treatment for metastatic breast cancer
-
1:20
dr. hurvitz on the evolution of treatment in metastatic her2 breast cancer
-
1:36
dr. mortimer on brain metastases in her2 breast cancer
-
1:15:22
ask me anything! | cancer recovery ep. 5
-
31:06
a cancer conversation - leptomeningeal disease clinic
-
5:05
anti-her2 mechanisms of approved her2 inhibitors
-
1:54
her2 positive metastatic breast cancer treatment options explained
-
2:03
dr. pegram on promising novel agents in her2 metastatic breast cancer
-
2:20
metastatic breast cancer - how we treat metastatic disease
-
3:15
neratinib for metastatic breast cancer
-
2:25
reducing risk in residual breast cancer
-
19:38
medical update: her2-positive metastatic breast cancer
-
1:49
dr. murthy on dual her2 blockade in her2 breast cancer
-
2:34
her2climb: sequencing in metastatic breast cancer
-
8:12
her2 testing in metastatic breast cancer
-
2:49
neratinib, trastuzumab fulvestrant for her2-mutant, hr , metastatic breast cancer
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis